Janos L. Tanyi, M.D., Ph.D.
Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania
Attending Physician, Gynecologic Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
Department: Obstetrics and Gynecology
Contact information
Department of Obstetrics and Gynecology
Jordan Center for Gynecologic Cancer at Penn
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard, 3 West
Philadelphia, PA 19104
Jordan Center for Gynecologic Cancer at Penn
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard, 3 West
Philadelphia, PA 19104
Office: 215-662-3318
Fax: 215-349-5849
Fax: 215-349-5849
Email:
janos.tanyi@uphs.upenn.edu
janos.tanyi@uphs.upenn.edu
Education:
M.D. (Summa cum Laude)
University of Debrecen, Faculty of Medicine, Hungary , 1993.
Ph.D. (Summa cum Laude)
Semmelweis University, Faculty of Medicine, School of Clinical Sciences, Budapest, Hungary, 2008.
Permanent linkM.D. (Summa cum Laude)
University of Debrecen, Faculty of Medicine, Hungary , 1993.
Ph.D. (Summa cum Laude)
Semmelweis University, Faculty of Medicine, School of Clinical Sciences, Budapest, Hungary, 2008.
Selected Publications
Ferrari AJ, Rawat P, Rendulich HS, Annapragada AV, Kinose Y, Zhang X, Devins K, Budina A, Scharpf RB, Mitchell MA, Tanyi JL, Morgan MA, Schwartz LE, Soong TR, Velculescu VE, Drapkin R: H2Bub1 loss is an early contributor to clear cell ovarian cancer progression. JCI Insight Page: 8(12):e164995. doi: 10.1172/jci.insight.164995. Jun 2023.Raffit Hassan, Marcus O. Butler, David Yoonsuk Oh, Roisin Eilish O'Cearbhaill, Lauren MacMullen, Erin Jeter, Udayan Guha, Viera P. Muzithras, Kevin Zikaras, Melissa Lynne Johnson, Janos Laszlo Tanyi, Azam Ghafoor, Robert Tighe, Munisha Smalley, Alfonso Quintas-Cardama, David S. Hong: Phase 1 trial of gavocabtagene autoleucel (gavo-cel, TC-210) in patients (pts) with treatment refractory mesothelioma and other mesothelin-expressing solid tumors. ASCO Annual Meeting, Chicago, IL Jun 2023.
Patrick Wagner, Edward Allen Levine, Alex Kim, Perry Shen, Nicole D. Fleming, Shannon Neville Westin, Laurel K Berry, Giorgos Constantine Karakousis, Janos Laszlo Tanyi, Madeline Olson, Brian Ostrander, Kartik Krishnan, David L. Bartlett: Detection of peritoneal metastases during cytoreductive surgery using pegsitacianine, a pH sensitive imaging agent: Final results from a phase 2 study. ASCO Annual Conference, Chicago, IL Jun 2023.
Haas AR, Golden RJ, Litzky LA, Engels B, Zhao L, Xu F, Taraszka JA, Ramones M, Granda B, Chang WJ, Jadlowsky J, Shea KM, Runkle A, Chew A, Dowd E, Gonzalez V, Chen F, Liu X, Fang C, Jiang S, Davis MM, Sheppard NC, Zhao Y, Fraietta JA, Lacey SF, Plesa G, Melenhorst JJ, Mansfield K, Brogdon JL, Young RM, Albelda SM, June CH, Tanyi JL: Two Cases of Severe Pulmonary Toxicity from Highly Active Mesothelin-Directed CAR T Cells. Mol Ther. Page: 12:S1525-0016(23)00316-7. doi: 10.1016, Jun 2023.
Bou-Samra P, Muhammad N, Chang A, Karsalia R, Azari F, Kennedy G, Stummer W, Tanyi J, Martin L, Vahrmeijer A, Smith B, Rosenthal E, Wagner P, Rice D, Lee A, Abdelhafeez A, Malek MM, Kohanbash G, Barry Edwards W, Henderson E, Skjøth-Rasmussen J, Orosco R, Gibbs S, Farnam RW, Shankar L, Sumer B, Kumar ATN, Marcu L, Li L, Greuv V, Delikatny EJ, Lee JYK, Singhal S: Intraoperative molecular imaging: 3rd biennial clinical trials update. J Biomed Opt Page: 28(5):050901. doi: 10.1117/1.JBO.28.5.050901, May 2023.
Nasioudis D, George EM, Tanyi JL: Controversies in the Staging of Patients with Locally Advanced Cervical Cancer. Diagnostics (Basel) Page: 13(10):1747, May 2023.
Pantel AR, Gitto SB, Makvandi M, Kim H, Medvedv S, Weeks JK, Torigian DA, Hsieh CJ, Ferman B, Latif NA, Tanyi JL, Martin LP, Lanzo SM, Liu F, Cao Q, Mills GB, Doot RK, Mankoff DA, Mach RH, Lin LL, Simpkins F.: [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study. Clin Cancer Res Page: 29(8):1515-1527. doi: 10.1158/1078-0432.CCR-22-1602, Apr 2023.
Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, Torigian DA, Rodriguez D, Smith SA, Dean E, Domchek SM, Drapkin R, Shih IM, Brown EJ, Hwang WT, Armstrong DK, Gaillard S, Giuntoli R, Simpkins F: Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) trial in acquired PARP-inhibitor-resistant homologous recombination deficient ovarian cancer. Clin Cancer Res Page: CCR-22-2444. doi: 10.1158/1078-0432.CCR-22-2444, Apr 2023.
Nugent ST, Raj LK, Latif NA, Cory L, Tanyi JL, Kovach SJ 3rd, Fischer JP, Fosnot J, Lin IC, Etzkorn JR, Shin TM, Giordano CN, Higgins HW 2nd, Walker JL, Miller CJ: A retrospective case series of Mohs micrographic surgery and interdisciplinary management of female genital skin cancers: Local recurrence rates and patient-reported outcomes. J Am Acad Dermatol Page: S0190-9622(23)00362-6. doi: 10.1016/j.jaad.2023.02.050, Mar 2023.
Ghezelayagh TS, Wu ES, Barber EL, Dao MD, Zsiros E, Urban RR, Gray HJ, Goff BA, Shah CA, Neubauer NL, Dai JY, Tanyi JL, Liao JB: Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study. Eur J Gynaecol Oncol Page: 44(1):17-25. doi: 10.22514/ejgo.2023.002, Feb 2023.